Our analysis of drug‐resistant breast cancer cells indicated that MET increased SCRIB expression, which then recruited MST1/2 and LATS1 to the plasma membrane, leading to YAP phosphorylation and its retention within the cytoplasm, and finally to inhibition of cell proliferation and invasion (Figure 7B). Here, LATS1 is linked to breast cancer.